|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
US10000574B2
(en)
|
2003-11-28 |
2018-06-19 |
Amgen Research (Munich) Gmbh |
Compositions comprising polypeptides
|
|
CN101128487B
(zh)
|
2004-12-02 |
2012-10-10 |
杜门蒂斯有限公司 |
靶向血清白蛋白和glp-1或pyy的双特异性结构域抗体
|
|
HRP20150175T1
(en)
|
2005-12-16 |
2015-03-27 |
Amgen Research (Munich) Gmbh |
Means and methods for the treatment of tumorous diseases
|
|
DK2211904T3
(en)
|
2007-10-19 |
2016-10-24 |
Seattle Genetics Inc |
Cd19-binding agents and uses thereof
|
|
EP2673297A2
(en)
|
2011-02-11 |
2013-12-18 |
Zyngenia, Inc. |
Monovalent and multivalent multispecific complexes and uses thereof
|
|
US9527925B2
(en)
|
2011-04-01 |
2016-12-27 |
Boehringer Ingelheim International Gmbh |
Bispecific binding molecules binding to VEGF and ANG2
|
|
WO2013013700A1
(en)
|
2011-07-22 |
2013-01-31 |
Affimed Therapeutics Ag |
Multivalent antigen-binding fv molecule
|
|
PE20141522A1
(es)
|
2011-08-17 |
2014-11-17 |
Glaxo Group Ltd |
Proteinas y peptidos modificados
|
|
WO2014012082A2
(en)
|
2012-07-13 |
2014-01-16 |
Zymeworks Inc. |
Multivalent heteromultimer scaffold design an constructs
|
|
AU2013289883B2
(en)
|
2012-07-13 |
2018-11-01 |
Zymeworks Bc Inc. |
Bispecific asymmetric heterodimers comprising anti-CD3 constructs
|
|
JP2017512814A
(ja)
|
2014-04-07 |
2017-05-25 |
シアトル ジェネティックス， インコーポレイテッド |
抗ｃｄ１９抗体および抗体−薬物結合体のための安定な製剤
|
|
UY36245A
(es)
|
2014-07-31 |
2016-01-29 |
Amgen Res Munich Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
|
CN120988137A
(zh)
|
2015-01-23 |
2025-11-21 |
赛诺菲 |
抗cd3抗体、抗cd123抗体和与cd3和/或cd123特异性结合的双特异性抗体
|
|
CN107406507A
(zh)
|
2015-02-12 |
2017-11-28 |
西雅图基因公司 |
使用cd19‑adc和长春新碱的组合疗法
|
|
CN114920848B
(zh)
|
2015-05-13 |
2024-10-11 |
埃博灵克斯股份有限公司 |
基于cd3反应性的t细胞募集多肽
|
|
US9708412B2
(en)
|
2015-05-21 |
2017-07-18 |
Harpoon Therapeutics, Inc. |
Trispecific binding proteins and methods of use
|
|
EP3322735A4
(en)
|
2015-07-15 |
2019-03-13 |
Zymeworks Inc. |
ACTIVE CONJUGATED BIS-SPECIFIC ANTIGEN-BONDING CONSTRUCTS
|
|
IL319047A
(en)
|
2015-08-28 |
2025-04-01 |
Amunix Operating Inc |
Chimeric polypeptide composition and methods for its preparation and use
|
|
WO2017055314A1
(en)
|
2015-10-02 |
2017-04-06 |
F. Hoffmann-La Roche Ag |
Bispecific anti-cd19xcd3 t cell activating antigen binding molecules
|
|
AU2016330807B2
(en)
*
|
2015-10-02 |
2023-08-10 |
F. Hoffmann-La Roche Ag |
Anti-human CD19 antibodies with high affinity
|
|
AU2016357460B2
(en)
*
|
2015-11-18 |
2023-07-27 |
Ablynx Nv |
Improved serum albumin binders
|
|
CN105399832A
(zh)
|
2015-12-07 |
2016-03-16 |
四川大学 |
一种无标签单链型人源双特异性抗体及其用途
|
|
KR20180133442A
(ko)
|
2016-04-13 |
2018-12-14 |
비비아 바이오테크 에스.엘. |
생체외 bite 활성화된 t 세포
|
|
EP3243836A1
(en)
|
2016-05-11 |
2017-11-15 |
F. Hoffmann-La Roche AG |
C-terminally fused tnf family ligand trimer-containing antigen binding molecules
|
|
WO2018098356A1
(en)
|
2016-11-23 |
2018-05-31 |
Harpoon Therapeutics, Inc. |
Psma targeting trispecific proteins and methods of use
|
|
FR3068662B1
(fr)
|
2017-07-04 |
2019-08-30 |
Le Joint Francais Snc |
Passe-cloison pour un organe destine a traverser une cloison
|
|
WO2019077062A1
(en)
|
2017-10-18 |
2019-04-25 |
Vivia Biotech, S.L. |
C-CELLS ACTIVATED BY BIT
|
|
JP7383704B2
(ja)
*
|
2018-06-07 |
2023-11-20 |
カリナン オンコロジー インコーポレイテッド |
多重特異性結合タンパク質およびその使用方法
|
|
US10815311B2
(en)
*
|
2018-09-25 |
2020-10-27 |
Harpoon Therapeutics, Inc. |
DLL3 binding proteins and methods of use
|
|
IL293725A
(en)
|
2019-12-11 |
2022-08-01 |
Cullinan Oncology Inc |
Anti-cd19 antibodies and multispecific binding proteins
|
|
IL293780A
(en)
|
2019-12-11 |
2022-08-01 |
Cullinan Man Inc |
Anti-serum albumin antibodies
|